Sign In
Buy RGBP
$0.0003
+0.00001 (+4.17%)
At Close: Jun 03, 2026
Presenting on Emerging Growth Conference 88 Day 1 on December 10; Register to live stream
08:10am, Tuesday, 09'th Dec 2025
MIAMI, Dec. 09, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth. com a leading independent small cap media portal announces the schedule of the 88th Emerging Growth Conference on December 10 and 11, 2025. The
Goldman Small Cap Research Publishes New Research Report on Regen BioPharma, Inc.
09:40am, Wednesday, 05'th Nov 2025
BALTIMORE, MD / ACCESS Newswire / November 5, 2025 / Goldman Small Cap Research, a stock market research firm specializing in the small cap and microcap sectors, announced today that it has published
Goldman Small Cap Research Publishes New Research Report on Regen BioPharma, Inc.
08:45am, Thursday, 17'th Jul 2025
Company Set to Make Migration from Preclinical to Clinical Stage BALTIMORE, MD / ACCESS Newswire / July 17, 2025 / Goldman Small Cap Research, a stock market research firm specializing in the small ca
Regen BioPharma, Inc. Expands Vision for Phase 1 Clinical Trial of HemaXellerate™
04:05pm, Tuesday, 19'th Nov 2024
Targeting Transformative Solutions for Aplastic Anemia and Beyond SAN DIEGO, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Regen BioPharma, Inc. (OTC Pink: RGBP and RGBPP) today provided further insight into its
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on September 25, 2024, At 4 pm Eastern Time
07:10pm, Monday, 23'rd Sep 2024
Regen BioPharma, Inc. invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference.
Regen BioPharma, Inc. invites individual and institutional investors, as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference. SAN DIEGO ,
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on January 10, 2024
08:00am, Monday, 08'th Jan 2024
Regen BioPharma, Inc. invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference. SAN DIEGO ,
Regen BioPharma, Inc. CEO Outlines Future Steps in CAR T Program
09:00am, Tuesday, 14'th Nov 2023
SAN DIEGO , Nov. 14, 2023 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP) has previously discussed initiation of its DuraCAR CAR T-cell therapeutic (https://www.prnewswire.co
Regen BioPharma, Inc. invites individual and institutional investors as well as advisors and analysts to attend its real-time, interactive presentation at the Emerging Growth Conference. SAN DIEGO, C
Regen BioPharma, Inc. Receives Second Phase Confirmatory Data on its Duracar CAR-T Cell Therapy Program
09:30am, Wednesday, 25'th Oct 2023
Autoimmunity to be Targeted SAN DIEGO , Oct. 25, 2023 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP) has previously discussed initiation of a series of experiments to valid
Goldman Small Cap Research Publishes New Research Report on Regen BioPharma, Inc.
09:25am, Wednesday, 04'th Oct 2023
BALTIMORE, MD / ACCESSWIRE / October 4, 2023 / Goldman Small Cap Research, a stock market research firm specializing in the small cap and microcap sectors, announced today that it has published a new
Initial Design and Testing Complete SAN DIEGO , Sept. 19, 2023 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP) had previously discussed initiation of a series of experiments
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on February 8, 2023
02:16pm, Tuesday, 07'th Feb 2023
Regen BioPharma, Inc. invites individual and institutional investors as well as advisors and analysts to attend its real-time, interactive presentation at the Emerging Growth Conference.
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on January 25, 2023
02:46pm, Monday, 23'rd Jan 2023
Regen BioPharma, Inc. invites individual and institutional investors as well as advisors and analysts to attend its real-time, interactive presentation at the Emerging Growth Conference. SAN DIEGO , J
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on November 30, 2022
02:49pm, Monday, 28'th Nov 2022
Regen BioPharma, Inc. invites individual and institutional investors as well as advisors and analysts to attend its real-time interactive presentation at the Emerging Growth Conference. SAN DIEGO , No
